Mad Hedge Technology Letter June 27, 2025 Fiat Lux Featured Trade: (SALESFORCE LOSING AT AI) (CRM), (AI)
Author Archives: april@madhedgefundtrader.com
Salesforce (CRM) and its stock are down around 19% YTD, and that goes to show that when you fall behind in the generative AI race, it starts to tank the stock. CRM has been on the back foot during the AI wars, and that has caused investors to become suspicious of the company. They only […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
(AUSTRALIAN HOUSEHOLD NET WEALTH IS GROWING) June 27, 2025 Hello everyone Apologies first for not being able to bring you the summary of John’s most recent webinar. I, along with many of you, if not all of you, have not been able to access John’s site. There is obviously a technical […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Global Market Comments June 27, 2025 Fiat Lux Featured Trade: (A BUY WRITE PRIMER), (AAPL)
27
Jun
Jun
I have a feeling we are going to do a lot of buying in 2025, so it’s time to refresh your knowledge about “Buy Writes.” There is always a way to make money in the stock market. Get the direction right, and the rest is a piece of cake. But what if the market is […]
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Mad Hedge Biotech and Healthcare Letter June 26, 2025 Fiat Lux Featured Trade: (HERE COMES THE ANTI-OZEMPIC) (REGN), (NVO), (LLY)
Back in the early 2000s, I remember a dinner with a hedge fund friend who swore Regeneron (REGN) would never be more than a one-trick pony with a laser pointer. That same pony is now gearing up to run a very different race. Regeneron is now dipping its toe into the trillion-calorie battlefield that is […]